Co-Authors
This is a "connection" page, showing publications co-authored by Katie Doores and Leticia Monin.
Connection Strength
0.463
-
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol. 2021 06; 22(6):765-778.
Score: 0.236
-
Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients. Cancer Cell. 2021 02 08; 39(2):257-275.e6.
Score: 0.058
-
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020 Dec; 26(12):1951.
Score: 0.057
-
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020 Oct; 26(10):1663.
Score: 0.057
-
A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020 10; 26(10):1623-1635.
Score: 0.056